Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05167409
Title A Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Criterium, Inc.
Indications

colorectal cancer

Therapies

Cetuximab + Evorpacept + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST